Antithrombotic Therapy in Preventing Ischemic Stroke

Stroke is associated with significant morbidity and mortality. Over 60% of cases are due to ischemic stroke, which is further divided into five subtypes. Antithrombotic therapy, i.e., antiplatelet or anticoagulant therapy, is a mainstay in the primary and secondary prevention of ischemic stroke. Recommendations for the use of antithrombotics vary by numerous factors, including stroke type. Antithrombotic therapy places patients at increased risk of bleeding, and pharmacists can ensure the safe and optimial use of these agents by educating patients on their proper use and monitoring patients for the occurrence of adverse drug events.